Clinical Trials Logo
  1. Home
  2. Myopathy
  3. NCT01547767

Investigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy

Myopathy Clinical Trial

Official title:
Investigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy

Clinical Trial Summary

Background: - A mutation in a gene known as ISCU was found to be the cause of a rare myopathy that affects the muscles. Researchers collected clinical samples from people with this myopathy. More research is being done to develop a therapy for this disease. Researchers are asking for permission to study the samples already collected. Objectives: - To allow researchers to use clinical samples collected to study new treatments for ISCU myopathy. Eligibility: - People with ISCU myopathy who have provided clinical samples for study. Design: - Participants will allow researchers to study clinical samples already collected. Blood, urine, muscle, and cell samples may be used. Medical records and photographs may also be studied. - Treatment will not be provided as part of this study.

Clinical Trial Description

In 2008, NIH investigators collaborated to find a mutation in the human gene, ISCU, which is the official human gene name for a gene involved in assembly of iron sulfur clusters, and is abbreviated from Iron Sulfur Cluster assembly protein, U, which was identified as the cause of a rare myopathy that affected about 25 patients in Sweden. This protocol is intended to allow for the collection and analysis of clinical specimens and medical information from several research subjects who previously participated in studies that led to identification of the disease gene. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01547767
Study type Observational
Source National Institutes of Health Clinical Center (CC)
Contact
Status Completed
Phase
Start date February 1, 2012
Completion date March 3, 2021
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT06374719 - WiTNNess - TNNT1 Myopathy Natural History Study
Not yet recruiting NCT03633565 - Comparative Study of Strategies for Management of Duchenne Myopathy (DM) Phase 4
Enrolling by invitation NCT02235220 - Reduction of Masticatory Muscle Activity by Restoring Canine Guidance N/A
Terminated NCT00278564 - Stem Cell Transplantation in Idiopathic Inflammatory Myopathy Diseases Phase 1
Completed NCT01642056 - EPI-743 for Metabolism or Mitochondrial Disorders Phase 1/Phase 2
Completed NCT02011282 - Electro-Neuro-Muscular Stimulation in ICU N/A
Completed NCT01702987 - Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS N/A
Active, not recruiting NCT01225614 - Efficacy and Tolerance of Early Launching of Nocturnal Non Invasive Phase 3
Recruiting NCT03749538 - Acute Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies N/A
Completed NCT02442986 - Neurological Outcome in Surgical and Non-surgical Septic Patients N/A
Recruiting NCT01022450 - Study of the Causes of the Breakdown of Muscle Fibers in Hospitalized Patients N/A
Withdrawn NCT00990834 - Muscle Characteristics Associated With Statin Therapy N/A
Active, not recruiting NCT00937001 - Critical Illness Myopathy as a Cause of Debilitating ICU-Acquired Weakness N/A
Recruiting NCT01353430 - Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD)
Completed NCT03751644 - Peripherical Neuromuscular Electrical Stimulation in Systemic Autoimmune Myopathies N/A
Completed NCT02765828 - Identification of Tongue Involvement in Late-Onset Pompe Disease
Recruiting NCT05599568 - Repeated Bout Effect i Neuromuscular Diseases N/A
Withdrawn NCT02124070 - Therapeutic Effect of Recombinant Human Growth Hormone (rhGH) on the Myopathy of Cystinosis Phase 1/Phase 2
Completed NCT02706314 - Impact of Human Blood Serum From Critically Ill Patients on Human Colon Neuronal Networks.
Recruiting NCT03042286 - SAPhIRE Statin Adverse Drug Reaction